April 25, Swiss drugmaker Roche's (ROG.S) first quarter sales rose a better-than-expected 10% on strong U.S. demand for rapid COVID-19 antigen tests and drugs including Ocrevus against multiple sclerosis as well as Hemlibra against haemophilia.... Read More >

For the three months ending March 31, total revenue was 74,283.49 million CNY compared to 39.53% growth in the year-ago period with the total profit of 35, 813.66 million CNY compared to 76.23% growth over the same period last year. ... Read More >

Existing methods for detecting and diagnosing COVID-19 are either expensive and complex or inaccurate. Read More >

Danaher reported on Thursday a 12 percent year-over-year increase in total revenues. Read More >

On April 19, Maccura Biotechnology Co., Ltd. released its 2021 annual financial report. The company achieved CNY 3.981 billion revenue in 2021, a year-on-year increase of 7.47%; net profit attributable to shareholders of listed companies was CNY 957 million, a year-on-year increa... Read More >

Abbott announced before the market opened on Wednesday that its first quarter Diagnostics business revenues grew 32 percent year over year. Read More >

With the help of single-cell sequencing, a team from Boston Children's Hospital, the Broad Institute, Harvard Medical School, and elsewhere has found evidence for enhanced somatic mutation in brain cells from individuals with Alzheimer's disease.... Read More >

A point-of-care COVID-19 test developed by researchers at the University of Illinois Urbana-Champaign can now detect and differentiate the alpha variant of the SARS-CoV-2 virus from earlier strains in saliva samples.... Read More >

Diagnostics instrument and reagent developer MicroGem announced on Tuesday that it has obtained Emergency Use Authorization from the US Food and Drug Administration for a rapid point-of-care PCR instrument and COVID test.... Read More >

On April 19, Mindary (300760.SZ) released its 2021 annual report, showing that in 2021 the company achieved revenue of CNY 25.270 billion, up 20.18%, achieved net profit attributable to the mother company of CNY 8.002 billion, up 20.19%. ... Read More >